| |
|

Umbilical Cord Stem Cells Could Repair Brain Injury.
TAMPA, Fla. (Feb. 18, 2001) – Stem cells
derived from human umbilical cord blood may help restore brain function
after disease or injury, according to new studies from USF and Henry
Ford Hospital in Detroit.
Results of several studies were presented Feb. 18th in San Francisco at
a meeting of the American Association for the Advancement of Science.
AAAS is the largest science organization, and publishes Science. An accompanying
AAAS press conference generated dozens of stories across the world, from
the Irish Times and the BBC to WebMD, the St. Petersburg Times, and the
Associated Press.
For the first time, the researchers have shown that human umbilical cord
stem cells, obtained after birth, can be reprogrammed to act as brain
cells (neurons and glia). Until now, umbilical cord stem cells have been
used to fight blood diseases such as leukemia in children.
"What we know from this is that umbilical cord blood contains stem
cells able to differentiate into neural cells," Paul Sanberg, PhD,
DSc, director of USF's Center for Aging and Brain Repair, said. Stem cells
are multipotent cells--able to grow into other kinds of cells.
"This finding suggests that umbilical cord blood is a noncontroversial,
readily available source of stem cells for brain repair," Dr. Sanberg
said.
"We already know that stem cells derived from embryonic tissue may
be effective in rebuilding the damaged brain in diseases like Parkinson's
and stroke."
Several scientists commented on the potential uses of these stem cells.
"There is a lot of exploring yet to go on. But theoretically this
could be the universal repair tissue," USF's Juan Sanchez Ramos,
MD, PhD, told the Associated Press.
In a related study, the team went on to inject human umbilical cord cells
in rats with stroke, and had surprising results that suggest that these
stem cells can restore function after stroke--even when the cells were
simply given intravenously.
"In the rats, the effects were fairly rapid, and new cord-derived
cells could be seen clearly on the stroke side of the brain," Dr.
Sanberg said.
The studies are funded through Florida's High Tech Corridor initiative.
The state awarded its grant based on the USF group's collaboration and
funding from CCEL Bio-Therapies, Inc., a subsidiary of CRYO-CELL International,
Inc., of Clearwater, Fla., which provided the cord blood to the research
team.
USF researchers are involved in several clinical trials using cell implants
into the brain to treat Huntington's disease, Parkinson's disease, and
the damage caused by stroke.
Principal researchers on these trials included Dr. Sanberg, who is director
of the USF Center for Aging and Brain Repair and director of Neurosurgical
Research; Dr. Sanchez Ramos, Professor of neurology and holder of the
Ellis Chair in Parkinson's Disease Research; Alison Willing, PhD, member
of the USF Center for Aging and Brain Repair; and Michael Chopp, PhD,
Professor and Vice Chairman of Neurology, Henry Ford Hospital.
|
|
|
|